Characteristics of hospitalized children infected with macrolide-resistant Mycoplasma pneumoniae

Brazilian Journal of Infectious Diseases

Volumn 18, Issue 3, 2014, Pages 294-299

  Komatsu, Haruki ^a,b   Tsunoda, Tomoyuki ^b   Inui, Ayano ^b   Sogo, Tsuyoshi ^b   Fujisawa, Tomoo ^b  

^a TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^b Eastern Yokohama Hospital   (Japan)

Author keywords

Antibiotics; Minocycline; Mutation; Young children

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; MACROLIDE; MINOCYCLINE; TOSUFLOXACIN; BETA LACTAM ANTIBIOTIC; ERYTHROMYCIN; JOSAMYCIN; NORFLOXACIN; RNA 23S; ROKITAMYCIN;

ADOLESCENT; ARTICLE; BACTERIAL PNEUMONIA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COUGHING; DRUG EFFICACY; DYSPNEA; FEMALE; FEVER; HOSPITALIZED CHILD; HUMAN; HYPOXIA; JAPAN; MACROLIDE RESISTANT MYCOPLASMA PNEUMONIAE; MACROLIDE RESISTANT MYCOPLASMA PNEUMONIAE INFECTION; MALE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NUCLEOTIDE SEQUENCE; OXYGEN SATURATION; OXYGEN THERAPY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SEQUENCE ANALYSIS; 23S RRNA GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HYPOXEMIA; LOWER RESPIRATORY TRACT INFECTION; NONHUMAN;

ANTIBIOTICS; MINOCYCLINE; MUTATION; YOUNG CHILDREN;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; MACROLIDES; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 84900003977     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2013.09.004     Document Type: Article

References (32)

1. Isozumi R., Yoshimine H., Morozumi M., Ubukata K., Ariyoshi K. Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae. Respirology 2009, 14:1206-1208.
2. Li X., Atkinson T.P., Hagood J., Makris C., Duffy L.B., Waites K.B. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr Infect Dis J 2009, 28:693-696.
3. Wolff B.J., Thacker W.L., Schwartz S.B., Winchell J.M. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother 2008, 52:3542-3549.
4. Morozumi M., Iwata S., Hasegawa K., et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob Agents Chemother 2008, 52:348-350.
5. Matsuoka M., Narita M., Okazaki N., et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother 2004, 48:4624-4630.
6. Cao B., Zhao C.J., Yin Y.D., et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis 2010, 51:189-194.
7. Dumke R., von Baum H., Luck P.C., Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect 2010, 16:613-616.
8. Chironna M., Sallustio A., Esposito S., et al. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother 2011, 66:734-737.
9. Morozumi M., Hasegawa K., Kobayashi R., et al. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob Agents Chemother 2005, 49:2302-2306.
10. Peuchant O., Menard A., Renaudin H., et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother 2009, 64:52-58.
11. Matsubara K., Morozumi M., Okada T., et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother 2009, 15:380-383.
12. Miyashita N., Maruyama T., Kobayashi T., et al. Community-acquired macrolide-resistant Mycoplasma pneumoniae in patients more than 18 years of age. J Infect Chemother 2013, 17:114-118.
13. Okada T., Morozumi M., Tajima T., et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis 2012, 55:1642-1649.
14. Berger R.S., Mandel E.B., Hayes T.J., Grimwood R.R. Minocycline staining of the oral cavity. J Am Acad Dermatol 1989, 21:1300-1301.
15. Chiappinelli J.A., Walton R.E. Tooth discoloration resulting from long-term tetracycline therapy: a case report. Quintessence Int 1992, 23:539-541.
16. Fleming P., Witkop C.J., Kuhlmann W.H. Staining and hypoplasia of enamel caused by tetracycline: case report. Pediatr Dent 1987, 9:245-246.
17. Grossman E.R. Tetracycline and staining of the teeth. JAMA 1986, 255:2442-2443.
18. Primosch R.E. Tetracycline discoloration, enamel defects, and dental caries in patients with cystic fibrosis. Oral Surg Oral Med Oral Pathol 1980, 50:301-308.
19. Sanchez A.R., Rogers R.S., Sheridan P.J. Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity. Int J Dermatol 2004, 43:709-715.
20. Ellison M.J. Vancomycin, metronidazole, and tetracyclines. Clin Podiatr Med Surg 1992, 9:425-442.
21. Grady R. Safety profile of quinolone antibiotics in the pediatric population. Pediatr Infect Dis J 2003, 22:1128-1132.
22. Grady R.W. Systemic quinolone antibiotics in children: a review of the use and safety. Expert Opin Drug Saf 2005, 4:623-630.
23. Sendzik J., Lode H., Stahlmann R. Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data. Int J Antimicrob Agents 2009, 33:194-200.
24. Abele-Horn M., Busch U., Nitschko H., et al. Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae. J Clin Microbiol 1998, 36:548-551.
25. Suzuki N., Yuyama M., Maeda S., Ogawa H., Mashiko K., Kiyoura Y. Genotypic identification of presumptive Streptococcus pneumoniae by PCR using four genes highly specific for S. pneumoniae. J Med Microbiol 2006, 55:709-714.
26. Kawai Y., Miyashita N., Yamaguchi T., et al. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumoniae in paediatric patients. Respirology 2012, 17:354-362.
27. McKenna B.E., Lamey P.J., Kennedy J.G., Bateson J. Minocycline-induced staining of the adult permanent dentition: a review of the literature and report of a case. Dent Update 1999, 26:160-162.
28. Westbury L.W., Najera A. Minocycline-induced intraoral pharmacogenic pigmentation: case reports and review of the literature. J Periodontol 1997, 68:84-91.
29. Cascio A., Di Liberto C., D'Angelo M., et al. No findings of dental defects in children treated with minocycline. Antimicrob Agents Chemother 2004, 48:2739-2741.
30. Hasegawa M., Sato Y., Kanayama A., et al. Antibacterial activity of tosufloxacin against major organisms detected from patients with the results obtained from organisms isolated about 10 years ago. J Infect Chemother 2006, 12:152-156.
31. Ikejima H., Yamamoto H., Ishida K., Kaku M., Shimada J. Evaluation of in-vitro activity of new quinolones, macrolides, and minocycline against Mycoplasma pneumoniae. J Infect Chemother 2000, 6:148-150.
32. Morozumi M., Takahashi T., Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother 2010, 16:78-86.